Best GHK-Cu Providers in 2026 — Ranked & Reviewed
GHK-Cu is a copper-binding peptide prescribed for skin, hair, and tissue repair, available compounded as an injection or a topical. As with every peptide in this category, the meaningful difference between sellers is whether a licensed clinician is involved at all. The providers below all prescribe through one, and each is independently scored.
Lowest verified price: $99/mo31 providers compared
New to GHK-Cu? Read our full GHK-Cu guide — evidence, dosing, safety and side effects.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
31 ghk-cu providers compared · independently scored against our six-factor methodology.
Compare the top providers at a glance
Logos, our editorial rating, price, medications, and coverage — the fastest way to narrow the list.
- ★ Editor's Pick
mainstream telehealth GLP-1 access
From /moCheck pricingCoverageCheck intakeMedicationsGHK-CuGlutathioneNAD+Sermorelin the lowest all-in monthly price we have verified on compounded semaglutide, labs included
From /moCheck pricingCoverage36 statesMedicationsBPC-157GHK-CuGlutathioneGonadorelinkpvMOTS-cnad-plusPT-141retatrutideSermorelinTB-500Tesamorelin- Nationwide Coverage
Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up
From /moCheck pricingCoverage50 statesMedicationsGHK-CuGlutathioneNAD+PT-141Sermorelin GLP-1 weight care alongside HRT, from board-certified physicians
From /moCheck pricingCoverageCheck intakeMedicationsGHK-Cucompounded GLP-1s from $83/mo all-in, with brand upgrade paths
From /moCheck pricingCoverage36 statesMedicationsGHK-CuGlutathioneNAD+Sermorelinlow-cost, physician-led compounded GLP-1 with peptide and hormone options
From /moCheck pricingCoverage50 statesMedicationsBPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneIpamorelinMOTS-cNAD+TB-500TesamorelinGLP-1 alongside men's and women's hormone-health programs
From /moCheck pricingCoverageCheck intakeMedicationsGHK-CuGlutathioneNAD+Sermorelinshoppers who want the pharmacy and medical group named before they buy
From /moCheck pricingCoverage50 statesMedicationsNAD+SermorelinGlutathioneGHK-CuMOTS-cCJC-1295 / Ipamorelin
| Provider | Rating | From /mo | Medications | Coverage | |
|---|---|---|---|---|---|
★ Editor's Pick mainstream telehealth GLP-1 access | Check pricing | GHK-CuGlutathioneNAD+Sermorelin | Check intake | Visit → | |
 the lowest all-in monthly price we have verified on compounded semaglutide, labs included | Check pricing | BPC-157GHK-CuGlutathioneGonadorelinkpvMOTS-cnad-plusPT-141retatrutideSermorelinTB-500Tesamorelin | 36 states | Visit → | |
Nationwide Coverage Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up | Check pricing | GHK-CuGlutathioneNAD+PT-141Sermorelin | 50 states | Visit → | |
 GLP-1 weight care alongside HRT, from board-certified physicians | Check pricing | GHK-Cu | Check intake | Visit → | |
 compounded GLP-1s from $83/mo all-in, with brand upgrade paths | Check pricing | GHK-CuGlutathioneNAD+Sermorelin | 36 states | Visit → | |
 low-cost, physician-led compounded GLP-1 with peptide and hormone options | Check pricing | BPC-157CJC-1295 / IpamorelinGHK-CuGlutathioneIpamorelinMOTS-cNAD+TB-500Tesamorelin | 50 states | Visit → | |
 GLP-1 alongside men's and women's hormone-health programs | Check pricing | GHK-CuGlutathioneNAD+Sermorelin | Check intake | Visit → | |
 shoppers who want the pharmacy and medical group named before they buy | Check pricing | NAD+SermorelinGlutathioneGHK-CuMOTS-cCJC-1295 / Ipamorelin | 50 states | Visit → |
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
Detailed Reviews
A note on prices below: any dollar figure in these provider summaries refers to that clinic’s GLP‑1 weight-loss program, not to GHK-Cu. The GHK-Cu price is the one beside each clinic in the comparison table above, read from that clinic’s own product page. Where it reads “Check pricing”, the clinic prescribes GHK-Cu but publishes no price for it — you are quoted after the consultation.
ShedRx
Verified partnerBest for: mainstream telehealth GLP-1 access
Telehealth provider offering compounded GLP-1 medications in injectable, lozenge, and drop formats.
Score Breakdown
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
Pepti
Best for: the lowest all-in monthly price we have verified on compounded semaglutide, labs included
Pepti is a Delaware-registered telehealth platform selling doctor-prescribed compounded peptides and GLP-1s across 36 states. Injectable semaglutide is $99 a month all-in and tirzepatide $199, each covering medication, physician review, baseline labs, refill management and shipping in a single flat price that does not rise with dose. The catalogue runs to more than 120 products across weight loss, hormones and TRT, recovery, cognitive and skin categories, plus at-home bloodwork. Pepti is a platform, not a prescriber, and does not bill insurance.
Score Breakdown
Pros
- ✓At $99/mo all-in, injectable semaglutide is among the cheapest verified prices in our catalogue.
- ✓States plainly that all doses cost one flat monthly price, so titrating up never raises the bill.
- ✓Publishes a page for each of the 36 states it serves, and the page count matches its claim exactly.
- ✓Names the reviewing physician, Dr. Gene Lee MD, and discloses pepti LLC as the Delaware operating entity.
Cons
- ✗The homepage shows an "FDA Cleared" badge beside peptide therapy, though product pages correctly say compounded drugs are not FDA-approved.
- ✗Neither the 503A nor the 503B compounding pharmacy is named, so you cannot check who dispenses.
- ✗The listed address, a Newark Delaware suite, is a shared registered-agent address rather than a clinical office.
- ✗Cash-pay only with no insurance billing, and the oral formulations jump to $249 and $399 a month.
YourHealthRx
Best for: Science-forward GLP-1 and peptide care, flat-rate dosing, built-in follow-up
YourHealthRx is a scientist-founded peptide and GLP-1 telehealth platform available in all 50 states and DC via a multi-state (IMLC) clinician network. Compounded semaglutide and tirzepatide come as a weekly injectable (with B12) or a daily oral tablet, at a flat subscription price that doesn't change with your dose - injectable semaglutide ~$170/mo and tirzepatide ~$210/mo ongoing. It also offers a broad peptide catalog plus lab testing. Prescribing runs through partner clinical workflows; compounded meds aren't FDA-approved, the pharmacy isn't named, and no LegitScript is shown.
Score Breakdown
Pros
- ✓Available in all 50 states and DC through a multi-state (IMLC) licensed clinician network
- ✓Compounded semaglutide and tirzepatide in two formats - weekly injectable (with B12) or daily oral dissolving tablet
- ✓Flat subscription price that doesn't change as your dose increases (no titration penalty)
- ✓Science-forward, clinician-led, with built-in follow-up, lab testing, and a broad peptide and longevity catalog (BPC-157, TB-500, sermorelin, NAD+)
- ✓Transparent, education-first positioning with published medical disclaimer, privacy, and terms
Cons
- ✗Eligibility and prescribing run through partner clinical workflows - YourHealthRx is the platform, not the prescriber or pharmacy
- ✗Compounded medications are not FDA-approved - not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- ✗The compounding pharmacy partner is not named ('transparent sourcing' claimed but no pharmacy disclosed)
- ✗Headline prices include a first-month intro rate; ongoing monthly cost is higher (semaglutide ~$170, tirzepatide ~$210)
- ✗No LegitScript certification displayed
Kina
Best for: GLP-1 weight care alongside HRT, from board-certified physicians
Kina is a menopause-care telehealth platform where GLP-1 is the weight-loss treatment, offered alongside HRT, peptide, and compounded options for menopause symptoms. Its GLP-1 program provides compounded semaglutide and tirzepatide from $179/month (plus a $50 physician consult; $0 membership), prescribed and monitored by board-certified physicians at Arora Health & Aesthetics. It carries verifiable LegitScript certification, is FSA/HSA eligible, ships free, and is cancel-anytime. Compounded medications are not FDA-approved; the pharmacy is not named.
Score Breakdown
Pros
- ✓Menopause-specialized care — GLP-1 weight treatment alongside HRT, peptide, and compounded options for menopause symptoms
- ✓Prescribed and monitored by named board-certified physicians at Arora Health & Aesthetics, with dose adjustments included
- ✓Verifiable LegitScript certification (seal ID 50917967)
- ✓GLP-1 from $179/month with $0 membership fees, FSA/HSA eligibility, free shipping, and cancel-anytime
- ✓Compounded semaglutide and tirzepatide, 100% online with a roughly 2-minute intake
Cons
- ✗Compounded medications are not FDA-approved — not brand Wegovy, Ozempic, Zepbound, or Mounjaro
- ✗Built for women navigating menopause — less tailored if that is not your situation
- ✗A separate $50 physician consultation fee applies on top of the medication price
- ✗The compounding pharmacy partner is not named, and the full list of served states is not published
PreventiveMD
Best for: compounded GLP-1s from $83/mo all-in, with brand upgrade paths
PreventiveMD is a physician-guided telehealth platform for GLP-1 weight loss and peptide therapy, offering compounded semaglutide from $83/mo all-in and compounded tirzepatide from $97/mo all-in, plus brand Wegovy, Zepbound, and Foundayo on a membership model. A US-licensed provider reviews each request within 24 hours; approved medication ships to your door with ongoing care through an online portal.
Score Breakdown
Pros
- ✓Compounded semaglutide from $83/mo and tirzepatide from $97/mo, billed as one all-in monthly price
- ✓Brand Wegovy, Zepbound, and Foundayo (oral GLP-1) available on the same platform
- ✓US-licensed provider reviews requests within 24 hours — no video visit required
- ✓You aren't charged until a provider approves; checkout places an authorization hold only
- ✓LegitScript-certified; works exclusively with state-licensed US 503A compounding pharmacies
- ✓HSA/FSA-eligible with receipts you can submit to your insurer
- ✓Publishes its state-availability list openly on the site
Cons
- ✗Individual compounding pharmacy partners are not publicly named
- ✗Not available in 14 states + DC, including New York, New Jersey, Virginia, and Wisconsin
- ✗Brand Wegovy, Zepbound, and Foundayo require a $49/mo membership fee on top of medication cost
- ✗'As low as' pricing — actual monthly cost can be higher depending on your plan
- ✗Orders become non-refundable once provider review or pharmacy fulfillment begins
How to choose a GHK-Cu provider
GHK-Cu is a copper-binding peptide sold two very different ways: as a cosmetic topical you can buy without a prescription, and as a compounded injectable that requires one. The price gap between them is not a discount — it is a different product.
What to look for
- Topical or injectable. Most of the published human work on GHK-Cu is topical, for skin and hair. Injectable GHK-Cu is compounded and prescription-only, with far less human data. Decide which you are buying before comparing prices.
- Concentration, stated. Topical GHK-Cu products vary enormously in copper-peptide concentration and most do not disclose it. A seller that publishes the percentage is giving you the only number that makes two products comparable.
- Evidence kept in proportion. Skin and wound-repair claims have the most support; systemic anti-aging claims have the least. A clinic that distinguishes the two is more trustworthy than one that does not.
Red flags to avoid
- “Research peptides” sold without a prescriber. Vials labelled “for research use only — not for human consumption” are sold outside the drug-approval system entirely, with no verified identity, purity, or sterility. Every peptide in this category is prescription-only in the US; if no licensed clinician is writing a prescription, you are not buying the same product.
- No named 503A or 503B compounding pharmacy. There is no FDA-approved finished product for these peptides, so every legitimate dose comes from a compounding pharmacy. A clinic that will not name the pharmacy it dispenses through is asking you to trust an unverifiable supply chain.
- “FDA-approved” claimed for a compounded peptide. Compounded drugs are not FDA-approved, and saying otherwise is a marketing violation, not a technicality. Some peptides once held an approval for a different indication in a discontinued brand — that is not the same as the compounded product being approved.
- Outcome claims with no trial behind them. Most peptides in this category have mechanistic or early-phase evidence, not randomized outcome trials. A clinic promising a specific fat-loss, muscle, or anti-aging result is selling ahead of the evidence — check our evidence review for the molecule before you commit.
- No baseline labs or follow-up for hormone-axis peptides. Growth-hormone secretagogues raise IGF-1, which is the point and also the thing to monitor. A clinic that never measures it cannot tell whether you are responding or over-dosed.
Every provider ranked above is scored against these criteria across our six-dimension methodology, and prices are re-verified against each provider’s live site.
How we rank & what counts as “legit”
Every provider in this ranking is scored against our published six-factor rubric[1] — value, effectiveness, user experience, trust & safety, accessibility, and support.
Brand-name Wegovy, Zepbound, Ozempic, and Mounjaro are separately FDA-approved under their own NDA numbers[4][5]. Published Phase 3 efficacy for semaglutide 2.4 mg (~14.9% mean weight loss over 68 weeks) comes from the STEP 1 trial[6], and for tirzepatide (~20.9% at the 15 mg dose over 72 weeks) from SURMOUNT-1[7]; the SURMOUNT-5 head-to-head published in 2025 compared the two directly[8].
Insurance coverage for anti-obesity medications varies widely by state Medicaid program and commercial plan[9][10]. Compounded and brand-name GLP-1s are generally FSA/HSA eligible with a prescription under IRS Publication 502[11].
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- 503A pharmacy · Pharmacy and drug forms
- 503A vs 503B (pharmacy compounding) · Pharmacy and drug forms
- 503B outsourcing facility · Pharmacy and drug forms
Sources & methodology — as of August 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 5.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 8.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
- 9.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 10.CMS — Medicaid prescription drug coverage policy (state-by-state)— Centers for Medicare & Medicaid Services.
- 11.IRS Publication 502 — Medical and Dental Expenses (HSA/FSA eligibility)— Internal Revenue Service.